SAD and MAD Study to Evaluate Safety, Tolerability, and Pharmacokinetics (PK) of TD-1473 in Healthy Subjects
Clinical trial NCT02657122 · COMPLETED
Trial details
- NCT number
- NCT02657122
- Sponsor
- Theravance Biopharma
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-01
- Primary completion
- 2016-04-01
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.